Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: Immunovant Inc (NASDAQ:IMVT), IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Twist Bioscience Corp (NASDAQ:TWST) and Arcutis Biotherapeutics Inc (NASDAQ:ARQT).
Kiniksa Pharmaceuticals has a consensus price target of $51.33.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $46.045 last updated April 9, 2026 at 11:29 AM EDT.
There are no upcoming dividends for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.